YOLFTbeta
Enorama Pharma AB

Enorama Pharma AB

ERMA · ST · Healthcare / Drug Manufacturers - Specialty & Generic

0.49SEK-0.21 (-29.60%)

Price History

Full chart

Market Stats

Previous Close0.696
Open0.688
Day Range0.48 – 0.688
52-Week Range0.241 – 3.00
Volume433.07K
Market Cap49.97M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.75
Dividend Yield0.00%
Beta1.80
50-Day Avg0.6452
200-Day Avg0.6935

About

Enorama Pharma AB (publ), a pharmaceutical company, develops, manufactures, and sells tobacco-free white snus in Sweden. It offers its products under the NIC-S brand name. The company was incorporated in 2006 and is based in Stockholm, Sweden.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Bengt Jönsson
  • Employees4
  • HeadquartersStrandvägen 7A, Stockholm, Sweden, 114 51, Sweden
  • Websitehttps://www.enorama.se

Leadership

  • Mr. Bengt JönssonCEO & Chairman of the Board · b. 1962

Financials

Income Statement

Currency: SEK2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue1.38M1.99M3.99M1.57M5.26M7.61M2.15M11.04M6.85M1.36M15.77M2.74M
Growth (%)-+44.14%+100.18%-60.59%+234.16%+44.80%-71.80%+414.26%-37.96%-80.17%+1061.12%-82.63%
Cost of Revenue-36.00K559.00K-3.99M-3.73M-6.72M-2.82M-219.00K8.90M7.46M5.26M12.06M64.52M
Gross Profit36.00K-559.00K7.98M5.31M11.98M10.43M2.37M2.13M-616.00K-3.90M3.70M-61.78M
Gross Margin2.60%-28.04%200.00%337.37%227.92%137.11%110.21%19.34%-9.00%-287.26%23.48%-2255.60%
Operating Expense0015.65M13.21M27.47M33.31M25.38M29.07M40.85M37.94M51.22M339.00K
Operating Income36.00K-559.00K-7.67M-7.91M-15.49M-22.88M-23.01M-26.94M-41.47M-41.84M-47.52M-62.12M
Operating Margin2.60%-28.04%-192.24%-502.59%-294.76%-300.58%-1072.27%-244.11%-605.67%-3080.85%-301.34%-2267.98%
EBITDA36.00K-559.00K88-7.91M-15.49M-22.72M-22.69M-26.28M-37.22M-43.05M-20.41M-61.65M
EBITDA Margin2.60%-28.04%0.00%-502.59%-294.62%-298.57%-1057.27%-238.10%-543.60%-3170.32%-129.41%-2250.86%
Net Income-20.00K-656.00K-7.84M-8.76M-16.34M-24.72M-23.90M-28.54M-41.78M-44.61M-43.81M-75.14M
Net Income Margin-1.45%-32.90%-196.33%-556.67%-310.87%-324.83%-1113.75%-258.64%-610.19%-3285.20%-277.82%-2743.30%
R&D--3.99M3.73M--393.00K1.76M2.87M2.87M19.97M-
R&D as % of Total Revenue--100.00%237.37%--18.31%15.97%41.95%211.41%126.63%-
Interest Expense56.00K97.00K163.62K850.61K846.85K923.00K445.00K802.00K1.27M883.00K2.99M12.64M
Interest Expense % of Total Revenue4.05%4.87%4.10%54.08%16.11%12.13%20.74%7.27%18.59%65.02%18.96%461.66%

Balance Sheet

Currency: SEK2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets3.69M9.17M13.63M15.49M38.83M42.58M40.91M50.93M48.72M34.38M15.89M8.26M
Total Liabilities1.03M2.64M4.55M8.13M21.81M35.40M39.13M29.58M17.20M14.85M8.09M31.71M
Total Equity2.66M6.52M9.08M7.36M17.02M7.18M1.78M21.35M31.52M19.54M7.80M-23.45M
Cash44841.00K3.83M164.76K16.43M14.61M4.73M12.20M4.14M6.15M2.08M3.04M
Total Debt600.00K850.00K3.55M3.25M1.55M25.00M5.71M3.79M1.91M436.00K--
Net Debt599.96K9.00K-277.55K3.09M-14.88M-14.61M975.00K-8.41M-2.23M-5.72M-2.08M-3.04M

Cash Flow

Currency: SEK2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow307.00K480.00K-6.11M-6.67M-13.36M-26.56M-23.00M-30.16M-32.96M-41.35M-35.70M-59.26M
Investing Cash Flow-1.38M-1.99M-3.99M-3.73M-7.17M-4.17M-3.84M-1.82M0000
Financing Cash Flow842.00K2.35M13.09M6.74M36.80M28.91M16.96M39.51M25.34M41.86M35.29M50.69M
Capital Expenditure1.38M1.99M3.99M3.73M7.17M4.17M3.84M1.82M00059.26M
Free Cash Flow-1.08M-1.51M-10.11M-10.40M-20.53M-30.73M-26.83M-31.99M-32.96M-41.35M-35.70M-59.26M
FCF to OCF-350.49%-315.42%165.27%156.01%153.68%115.70%116.68%106.04%100.00%100.00%100.00%100.00%

Earnings

Report DateJun 30, 2016Sep 30, 2016Dec 31, 2016Mar 31, 2017Jun 30, 2017Sep 30, 2017Dec 31, 2017Mar 31, 2018Jun 30, 2018Sep 30, 2018Dec 31, 2018Mar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Mar 31, 2020Jun 30, 2020Sep 30, 2020Dec 31, 2020Mar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Mar 4, 2024Jun 27, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate-----------------------------------------
EPS Actual-0.62-0.20-0.34-0.28-0.33-0.38-0.53-0.51-0.53-0.57-1.12-0.71-0.64-1.18-1.10-0.68-0.28-0.72-1.28-0.84-0.73-1.10-1.01-1.17-1.14-0.82-1.12-0.32-0.25-0.32-0.29-0.19-0.14-0.12-0.36-0.37-0.28-0.18-0.28-0.17-0.18
Surprise-----------------------------------------
Timing------------------------------After-hoursAfter-hours---------

Key Statistics & Ratios

Market Cap49.97M
Enterprise Value48.04M
Trailing P/E0.00
Forward P/E0.00
Price / Sales34.54
Price / Book19.30
EPS-0.75
Book Value-0.676
Revenue (TTM)1.45M
Gross Profit (TTM)-4.85M
EBITDA-54.49M
Profit Margin0.00%
Operating Margin-8708.82%
Return on Equity-526.84%
Return on Assets-213.34%
Shares Outstanding74.59M
Shares Float15.81M
Beta1.80
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Mar 6, 2024154:127
  • Oct 29, 20181903:1860